CSIR India and Laxai LifeSciences Pvt Ltd initiate phase II clinical trial with anti-helminitic drug Niclosamide for treatment of Covid-19
New Delhi, June 06 CSIR India and Laxai LifeSciences private limited have initiated phase II clinical trial with anti-helminitic drug
Read more